In addition, in diabetes, myo-inositol intracellular concentrations were reduced by the upregulation of the myo-inositol-degrading enzyme myo-inositol oxygenase (MIOX), a tubular-specific enzyme, and the glucuronate xylulose pathway was activated [20,21,22]. This evidence concerns the gene MIOX and diabetes mellitus.